CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Cogent Bioscience (COGT) Files New Drug Application For Bezuclastinib

NDA FilingBezuclastinibPositive
AI Analysis

Summary

Cogent Bioscience has filed a New Drug Application for bezuclastinib with the FDA, advancing the drug candidate toward potential regulatory approval.

Importance:6/10
Sentiment:
0.50
NDA_filingregulatory_submissiondrug_development
Related Companies

Read the original article

Published by yahoo_finance on July 15, 2026 2:01 PM

Read Original